Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...
History suggests Nvidia should modestly beat Eli Lilly over the next roughly two months,” notes a DataTrek analyst — but ...
TipRanks on MSN
Eli Lilly’s phase 2 study on imlunestrant: A potential game-changer in breast cancer treatment
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...
As Eli Lilly gears up to support its partnered athletes, Team USA and the Games themselves at the Milano Cortina 2026 Olympic ...
MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreement with Eli Lilly and Company (Lilly) to advance a ...
Judges allow consolidation of vision loss lawsuits filed against Novo Nordisk and Eli Lilly over diabetes and weight loss ...
Very few investors can match Stanley Druckenmiller. He delivered an average annual return of over 30% over three decades at ...
U.S. Olympians Elana Meyers Taylor and Gabby Thomas participated in a social video, drawing a throughline between their ...
It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive ...
TipRanks on MSN
Eli Lilly’s pediatric COVID-19 study on baricitinib terminated: Key insights for investors
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) recently updated its clinical study ...
Rensselaer Central senior Kendra Kohlhagen has been named the 2026 Lilly Endowment Community Scholarship winner for Jasper ...
Philadelphia has lagged in biotech R&D jobs despite University of Pennsylvania scientists playing a leading role in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results